Evaluation of HMGB1 Expression as a Clinical Biomarker for Cholangiocarcinoma
HMGB1 in both tissue biopsies and blood serum shows potential as a predictive biomarker in CCA patients. These biomarkers could form the basis for facilitating more effective treatment planning.
Authors
- Anchalee Techasen (ORCID: https://orcid.org/0000-0002-4230-5641)
- Phongsaran Kimawaha
- Raynoo Thanan (ORCID: https://orcid.org/0000-0002-9001-1197)
- Malinee Thanee (ORCID: https://orcid.org/0009-0007-6163-3740)
- Wassana Jamnongkan
- Apinya Jusakul (ORCID: https://orcid.org/0000-0001-7652-7771)
- SONGPOL HAOHAN
- Papitchaya Sirithawat
- Attapol Titapun (ORCID: https://orcid.org/0000-0002-2228-752X)
- Supakan Amontailak (ORCID: https://orcid.org/0009-0005-2923-1288)
Institutions
- Khon Kaen University (TH)
Publication Details
- Journal
- Cancer Genomics & Proteomics
- Published
- 2024-12-27
- DOI
- https://doi.org/10.21873/cgp.20489
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Khon Kaen University